BPB Medica
BPB Medica is an Italian medical device manufacturer (founded 1999, Mirandola) selling proprietary devices across six verticals — Biopsy, Spine, Ortho-biologics, ART, ICU, and Aesthetic — to hospitals, fertility clinics, and specialist physicians worldwide, with EU MDR compliance and clinical academy-led physician training.
- Company typePrivate
- Founded1999
- HeadquartersMirandola, Italy
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What BPB Medica does
BPB Medica (legal entity: BIOPSYBELL S.R.L. Società unipersonale) is an Italian medical device manufacturer founded in 1999 and headquartered in Mirandola, Italy, within the country's principal medical device manufacturing cluster. The company is a wholly-owned subsidiary of Bpunto3 S.r.l. and operates with a workforce of 51-100 employees. It maintains compliance with EU Medical Device Regulation 2017/745 across its product portfolio.
The company sells across six specialty verticals: Biopsy, Spine, Ortho-biologics, Assisted Reproduction Technology (ART), Intensive Care, and Aesthetic Medicine. Its technology base includes proprietary devices for minimally invasive spinal procedures (including percutaneous discectomy kits) and the Lipogems adipose-derived mesenchymal stem cell processing platform, with documented clinical case reports such as LIPO-STEM DUO in chondrogenic differentiation supporting orthobiologics indications. Core products are manufactured in-house and distributed through a mix of direct sales and distributor channels.
BPB Medica reaches its customer base — primarily hospital departments, fertility clinics, intensive care units, and specialist physicians — through participation in major international congresses (EUROSPINE, NASS, MEDICA, SIA, ESICM, AAB, ESHRE) and through dedicated clinical training academies including the Milan Percutaneous Discectomy Academy and the Verona Pain Academy. Revenue is generated through device and consumable sales tied to procedure volumes, with academy and congress presence functioning as physician adoption and KOL development channels rather than separate monetization streams.
BPB Medica firmographics
Firmographics- Name
- BPB Medica
- Legal name
- BIOPSYBELL S.R.L. Società unipersonale
- Website
- https://biopsybell.it
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BPB Medica is an Italian medical device manufacturer (founded 1999, Mirandola) selling proprietary devices across six verticals — Biopsy, Spine, Ortho-biologics, ART, ICU, and Aesthetic — to hospitals, fertility clinics, and specialist physicians worldwide, with EU MDR compliance and clinical academy-led physician training.
- Ownership category
- akta.pro rank
Where BPB Medica is headquartered
LocationHeadquarters
- HQ city
- Mirandola
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
BPB Medica business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: BPB Medica generates revenue through the manufacture and sale of medical instruments for minimally invasive surgery. The company operates as an Italian-based healthcare manufacturer with in-house production capabilities, selling devices across six product categories: Spine, Ortho-biologics, Assisted reproduction technology, Biopsy, Aesthetic, and Intensive care.
Go-to-market motion3 records
Distribution channels2 records
Marketing channels7 records
BPB Medica product offering
Product offeringCore offering
BPB Medica (legally BIOPSYBELL S.R.L. Società unipersonale) designs, manufactures and sells minimally invasive surgery (MIS) medical devices across six clinical areas: biopsy, spine, ortho-biologics, assisted reproduction technology (ART), intensive care and aesthetics. Its products are sold to healthcare professionals and medical institutions, with portfolio offerings such as the LIPO-STEM DUO™ system serving as sub-product brands within the broader MIS device lines.
Product overview
BPB Medica is an Italian-based healthcare manufacturer specializing in medical instruments for minimally invasive surgery. The company operates a fully integrated, in-house production model. Its product portfolio consists of six core product lines: Biopsy (tissue sampling devices), Spine (surgical instruments for vertebroplasty/kyphoplasty), Ortho-biologics (including LIPO-STEM DUO™ for regenerative medicine), Assisted Reproduction Technology, Intensive Care, and Aesthetic. The products serve healthcare professionals across multiple surgical and medical care specialties, with an emphasis on precision instruments that improve patient outcomes and simplify procedures.
Differentiator
Problem solved
Functional benefit
Brands
- BIOPSYBELL: Primary brand name and website domain for BPB Medica's medical devices for minimally invasive surgery
Products and services
- Biopsy Devices Line of minimally invasive biopsy instruments and devices used by clinicians to obtain tissue samples; targeted at healthcare professionals and pathology/oncology specialists.
- Spine Devices Minimally invasive spinal implant and instrumentation line for spinal surgery applications, sold to spine surgeons, hospitals and surgical centers.
- Ortho-biologic Products Ortho-biologic devices and materials used in orthopedic regenerative and surgical procedures, marketed to orthopedic surgeons and hospitals.
- Assisted Reproduction Technology (ART) Devices Devices and instruments used in assisted reproduction technology procedures, targeted at fertility clinics and reproductive medicine specialists.
- Intensive Care Devices Minimally invasive devices used in intensive care settings, sold to ICUs, critical care physicians and hospital departments.
- Aesthetic Devices Minimally invasive devices for aesthetic and cosmetic procedures, marketed to aesthetic medicine practitioners and clinics.
- LIPO-STEM DUO™ Sub-product/brand in the BPB Medica portfolio used in fat grafting and regenerative procedures, targeted at plastic surgeons and aesthetic medicine professionals.
Quantifiable outcome
- LIPO-STEM DUO™ featured in international case report for regenerative medicine in neuromodulation
- +2 more outcomes
Companies that use BPB Medica
Customer profileSegments2 records
Ideal customer profiles1 record
BPB Medica technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
BPB Medica partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Milan Percutaneous Discectomy AcademycoreBPB Medica supports spine surgery specialist training through the Milan Percutaneous Discectomy Academy. This partnership enables hands-on education for medical professionals in percutaneous discectomy techniques, aligning with the company's spine product line and strengthens relationships with spine surgery specialists who are potential device users.
- Verona Pain AcademycoreBPB Medica supports the Verona Pain Academy, a hands-on academy advancing clinical knowledge in osteoarthritis and regenerative techniques. This partnership aligns with the company's ortho-biologics product line and provides educational engagement with regenerative medicine specialists.
Scale indicators2 records
Recent moves5 records
Expansion highlights4 records
BPB Medica competitors and assessment
Company assessmentBroad incumbents
- Zimmer Biomet: Global orthopedic and spine medical device manufacturer. Overlaps with BPB's spine surgery instruments and ortho-biologics product lines as a broad incumbent.
- Hologic: Women's health-focused medical device company with a leading biopsy product line. Directly comparable to BPB's biopsy product category and its assisted reproduction technology portfolio.
- Stryker: Diversified medical device manufacturer with spine, surgical instruments, and orthopedic offerings. Overlaps directly with BPB's MIS surgical instruments and spine product lines as a large incumbent.
- Conmed: Medical device company with a biopsy and MIS surgical instrument portfolio. Overlaps with BPB's biopsy and spine product lines and competes in similar hospital channels.
- Becton Dickinson (BD): Large medical technology company with biopsy, surgical, and intensive care product lines. Overlaps with BPB across biopsy and intensive care categories.
- Medtronic: Global medical device leader with extensive spine, MIS, and ortho-biologics portfolios. Competes with BPB across multiple of its six product lines but at much greater scale and with broader geographic reach.
Direct peers
- Globus Medical: Specialist spine surgery device company with strong MIS spine portfolio including kyphoplasty/vertebroplasty products. The most direct peer to BPB's spine product line given overlapping procedural focus.
- RTI Surgical: Orthopedic and surgical implant company with biologics offerings. Comparable to BPB's ortho-biologics and spine regenerative medicine focus.
- Merit Medical Systems: Manufacturer of biopsy needles, spine intervention tools, and other MIS devices. Closely comparable to BPB's biopsy and spine product categories, with a similar mid-cap European/American profile.
Regional players
- Coloplast: European-headquartered medical device company with surgical and specialty care products. Comparable as a European mid-to-large med device peer, though with different specialty mix.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Customer concentration
BPB Medica social profiles
Digital presenceBPB Medica compliance and trust
Trust signalCompliance1 record
BPB Medica financial estimates
Financial estimateRevenue estimate
Valuation estimate
BPB Medica leadership team
Management profileNumber of profiles
Profiles1 record
BPB Medica funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BPB Medica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BPB Medica
What does BPB Medica do?
BPB Medica (legally BIOPSYBELL S.R.L. Società unipersonale) designs, manufactures and sells minimally invasive surgery (MIS) medical devices across six clinical areas: biopsy, spine, ortho-biologics, assisted reproduction technology (ART), intensive care and aesthetics. Its products are sold to healthcare professionals and medical institutions, with portfolio offerings such as the LIPO-STEM DUO™ system serving as sub-product brands within the broader MIS device lines.
Is BPB Medica a public or private company?
BPB Medica is a private company. It is classified as family owned and is currently operating.
When was BPB Medica founded?
BPB Medica was founded in 1999. It employs 11 to 50 people.
Where is BPB Medica based?
BPB Medica is headquartered in Mirandola, Italy, in the Europe region.
How does BPB Medica make money?
One revenue line is on record: medical Device Sales.
Who are BPB Medica's main competitors?
Broad incumbents on record are Zimmer Biomet, Hologic, Stryker, Conmed, Becton Dickinson (BD) and Medtronic. Direct peers are Globus Medical, RTI Surgical and Merit Medical Systems. Coloplast is listed as a regional player.
Does BPB Medica have an API?
No public API is recorded for BPB Medica.